These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26359451)

  • 1. Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.
    Dosch JS; Ziemke EK; Shettigar A; Rehemtulla A; Sebolt-Leopold JS
    Cancer Res; 2015 Nov; 75(21):4582-92. PubMed ID: 26359451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells.
    Zhang GN; Liang Y; Zhou LJ; Chen SP; Chen G; Zhang TP; Kang T; Zhao YP
    Cancer Lett; 2011 Dec; 313(2):137-44. PubMed ID: 22030254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
    Du Z; Qin R; Wei C; Wang M; Shi C; Tian R; Peng C
    Dig Dis Sci; 2011 Mar; 56(3):741-50. PubMed ID: 20683663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors.
    Sobrevals L; Mato-Berciano A; Urtasun N; Mazo A; Fillat C
    Stem Cell Res; 2014 Jan; 12(1):1-10. PubMed ID: 24141108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.
    Yao J; Cai HH; Wei JS; An Y; Ji ZL; Lu ZP; Wu JL; Chen P; Jiang KR; Dai CC; Qian ZY; Xu ZK; Miao Y
    Oncol Rep; 2010 May; 23(5):1375-82. PubMed ID: 20372854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin suppresses tumor angiogenesis and enhances the chemosensitivity of gemcitabine in a genetically engineered mouse model of pancreatic cancer.
    Qian W; Li J; Chen K; Jiang Z; Cheng L; Zhou C; Yan B; Cao J; Ma Q; Duan W
    Life Sci; 2018 Sep; 208():253-261. PubMed ID: 30053447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-like cells?
    Wang D; Zhu H; Liu Y; Liu Q; Xie X; Zhou Y; Zhang L; Zhu Y; Zhang Z; Su Z
    Biomed Res Int; 2014; 2014():760303. PubMed ID: 24689055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells.
    Vaz AP; Ponnusamy MP; Rachagani S; Dey P; Ganti AK; Batra SK
    Br J Cancer; 2014 Jul; 111(3):486-96. PubMed ID: 25003666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
    Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system.
    Fredebohm J; Boettcher M; Eisen C; Gaida MM; Heller A; Keleg S; Tost J; Greulich-Bode KM; Hotz-Wagenblatt A; Lathrop M; Giese NA; Hoheisel JD
    PLoS One; 2012; 7(11):e48503. PubMed ID: 23152778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
    Verma RK; Yu W; Shrivastava A; Shankar S; Srivastava RK
    Sci Rep; 2016 Sep; 6():32743. PubMed ID: 27624879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
    Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
    Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.
    Shimizu K; Chiba S; Hori Y
    PLoS One; 2013; 8(11):e81283. PubMed ID: 24278411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.
    Knoop RF; Sparn M; Waldmann J; Plassmeier L; Bartsch DK; Lauth M; Hudemann C; Fendrich V
    Neoplasia; 2014 Jun; 16(6):463-70. PubMed ID: 24953430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
    Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.